주식/증권
📈 긍정적
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
요약
Champions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement and operational initiatives support progress.